Skip to main content

  • With Specific Implantation Strategy, Absorb BVS Shows Good Results at 5 Years Post-STEMI

    Prolonged DAPT also associated with better outcomes in BVS STEMI STRATEGY-IT

    Patients who were implanted with the Absorb bioresorbable vascular scaffold with a prespecified implantation strategy after presenting with ST-elevation myocardial infarction (STEMI) showed low rates of adverse events and scaffold thrombosis at 5-year follow-up, according to new BVS STEMI STRATEGY-IT results presented Tuesday.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details